MAPT and Brain atrophy: Both plasma NfL and T-tau have been found to be elevated in stroke patients, and among those with other cardiovascular conditions; the combination of having both higher NfL and T-tau, compared to either alone, was more strongly associated with lower memory, global cognitive decline, brain atrophy and a higher number of infarcts cross-sectionally (82).